← Back
$ATNF All transactions

180 Life Sciences Corp.

A

$ Value

$0

Shares

3,908,986

Price

$0

Filed

Aug 6

Insider

Name

Smith Ryan Lewis

Title

CIK

0001619129

Roles

Director

Transaction Details

Transaction Date

2025-07-29

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,908,986

Footnotes

The options were granted under the 2025 Supplemental Option Plan of the Issuer. The options vested immediately, but were not exercisable until or unless the closing of the transactions contemplated by the July 29, 2025, Securities Purchase Agreement between the Issuer and the purchasers set forth therein occurred, which closing date was August 4, 2025. Separately, the options are not exercisable until stockholder approval of the 2025 Plan is received. If stockholder approval is not received prior to July 29, 2026, the options will be cancelled. | Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a director of the Issuer.

Filing Info

Accession No.

0001213900-25-072758

Form Type

4

Issuer CIK

0001690080

Smith Ryan Lewis's History

Date Ticker Type Value
2026-04-02 FRMM A $0
2026-03-31 USEG $13K
2026-03-19 USEG F $20K
2026-03-04 USEG A $0
2026-02-18 ETHZ J $0
2026-02-13 USEG F $39K
2026-01-05 USEG F $21K
2025-12-01 ETHZ G $0
2025-12-01 ETHZ G $0
2025-11-14 ETHZ G $0

Other Insiders at ATNF (90d)

Insider Bought Sold Last
New Jason Griffin 2026-04-02
Rudisill McAndrew
Chief Executive Officer
2026-04-02
Smith Ryan Lewis 2026-04-02
Dalton Angela 2026-04-02
SUCKLING ANDREW P 2026-04-02
Heter Crystal Jane 2026-04-02
Saunders John Tazewell
Chief Financial Officer
2026-04-02
Edwards Michael A 2026-04-02